Basic Study
Copyright ©The Author(s) 2019.
World J Diabetes. Dec 15, 2019; 10(12): 546-559
Published online Dec 15, 2019. doi: 10.4239/wjd.v10.i12.546
Table 1 Glucose concentration in rats’ blood
Glucose concentration in rats’ blood, mmol/L
The 9th d after STZ administrationThe 11th d after STZ administration
Control group5.09 ± 0.0815.41 ± 0.088
Animals with experimental hyperglycemia induced by streptozotocin10.01 ± 0.166a14.6 ± 0.241a
SkQ1 is administered to animals with pathology6.04 ± 0.099b5.87 ± 0.096b
SkQ1 is administered to animals at control group5.1 ± 0.0835.30 ± 0.086
Table 2 Parameters reflecting the level of free radical processes and general antioxidant system activity
ParametersExperiment conditions
Control groupAnimals with experimental hyperglycemia induced by streptozotocinSkQ1 is administered to animals with pathologySkQ1 is administered to animals at control group
Biochemicoluminescence measurements
Light sum, mV × cHeart485.01 ± 7.9121062.76 ± 17.124a818.76 ± 13.611b478.33 ± 7.971
Blood serum307.70 ± 5.141654.14 ± 10.114a410.53 ± 6.713b302.33 ± 5.012
Maximum flash intensity, mVHeart51.53 ± 0.851126.93 ± 1.987a83.10 ± 1.374b47.33 ± 0.779
Blood serum25.20 ± 0.41252.23 ± 0.864a33.67 ± 0.559b22.15 ± 0.362
Angle tangent of slope of kinetic curve of biochemicoluminescence pathwayHeart7.10 ± 0.10114.94 ± 0.241a10.10 ± 0.165b7.05 ± 0.112
Blood serum13.33 ± 0.22330.43 ± 0.498a21.71 ± 0.359b12.93 ± 0.183
Content of conjugated dienes, μmol/mLHeart17.70 ± 0.28141.90 ± 0.687a29.76 ± 0.492b17.22 ± 0.267
Blood serum7.55 ± 0.12224.83 ± 0.401a15.00 ± 0.247b7.33 ± 0.113
Level of carbonyl compounds, nmol/L/mg of proteinHeart0.072 ± 0.0010.199 ± 0.003a0.136 ± 0.002b0.070 ± 0.001
Blood serum0.021 ± 0.00030.154 ± 0.002a0.076 ± 0.001b0.019 ± 0.0003
Citrate content, nmol/LHeart0.201 ± 0.0030.43 ± 0.007a0.28 ± 0.004b0.204 ± 0.003
Blood serum0.57 ± 0.00971.45 ± 0.0211.07 ± 0.016b0.59 ± 0.0093